In the first study of transcriptomic changes in depression in AD (under review), we similarly found changes in NFKB signaling and network information flow differences in both GSK3B and TGFB, a signaling cascade that is often in opposition to NFKB. Here, NFKB1 is linked to depressive symptom measurement.